21st Feb 2017 11:42
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | BB Healthcare Trust plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | ||||
Other (please specify): | i. Type 1 disclosure as per the Transparency Directive II Regulation ii. Change in the issuer's Total Voting Rights | ü | ||
3. Full name of person(s) subject to thenotification obligation: iii | Schroders plc | |||
4. Full name of shareholder(s) (if different from 3.):iv | ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 17.02.17 | |||
6. Date on which issuer notified: | 20.02.17 | |||
7. Threshold(s) that is/are crossed orreached: vi, vii | Below 5% | |||
8. Notified details: | ||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||
Ordinary | 8,064,100
| 8,064,100
| 8,064,100
| N/A
| 8,064,100
| N/A
| 4.996%
| |||||||
GB00BZCNLL95
| ||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |||||||||
Nominal | Delta | |||||||||||||
Total (A+B+C) | ||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||
8,064,100 | 4.996% | |||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
Schroder & Co. Limited 7,746,100 4.799%
Schroders (C.I.) Limited 318,000 0.197% | ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will ceaseto hold: | ||
12. Date on which proxy holder will cease to holdvoting rights: | ||
13. Additional information: | The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issue share capital amount 161,420,675. | |
14. Contact name: |
Shaheen Hussain | |
15. Contact telephone number: |
020 7658 6000 | |
Enquiries:
Anthony Lee | 020 7653 9690 |
PraxisIFM Fund Services (UK) Limited |
Related Shares:
Bellevue HealthSchroders